Cross Atlantic Capital Partners is a venture capital firm that manage four venture funds with over $500 million in total capital under management. Raised in 1999, Cross Atlantic Technology Fund I is a $120 million fund and was followed-on in 2001 by an $88 million fund, Cross Atlantic Technology Fund II. Additionally, they manage $300 million in two co-investment funds for the Pennsylvania Public School Employees' Retirement System (PSERS). The first of these Co-Investment Funds, Co-Investment Fund 2000, is a $150 million fund and was followed on in 2005 by another $150 million fund, Co-Investment Fund II.
Their primary investment focus is in the commercialization of patented or specialty know-how in early to mid-stage technology companies.
They maintain offices in Radnor, Pennsylvania, Dublin, Ireland and Edinburgh, Scotland.
Cross Atlantic Capital Partners has made 50 investments. One investment was on Oct 2, 2014, when Rootstock Software raised $1M. Cross Atlantic Capital Partners has had 13 exits. Cross Atlantic Capital Partners's most notable exits include MetaPack, Labcyte, and HexaTier.
Cross Atlantic Capital Partners has $12.9M in estimated revenue annually. Cross Atlantic Capital Partners competes with Meakem Becker Venture Capital, Robin Hood Ventures, and Penn Venture Partners.
Timeline
Funded Companies
Labcyte is a global biotechnology tools company headquartered in San Jose, California, that develops tools for liquid handling.
Dianrong is a Shanghai-based peer-to-peer lending marketplace where users can invest in other people or small businesses, or individuals or businesses can find financial support.
People
Donald R. Caldwell
Managing Director
Frederick C. Tecce
Managing Director
R. Carter Caldwell
Managing Director
